Clinical trial

VITATOPS: A Study of VITAmins TO Prevent Stroke

NCT00097669 · VITATOPS, Other · Completed

Key facts

NCT number NCT00097669
Title VITATOPS: A Study of VITAmins TO Prevent Stroke
Official title VITATOPS - A Study of VITAmins TO Prevent Stroke
Lead sponsor VITATOPS, Other
Collaborators National Health and Medical Research Council, Australia National Heart Foundation, Australia Medical Health Research Infrastructure Council, Australia
Status Completed
Study type Interventional
Conditions Stroke, Transient Ischemic Attack
Intervention type Drug, Other
Interventions Active VITATOPS Tablet (folic acid 2mg, B6 25mg, B12 500ug) or placebo, Placebo
Enrollment 8,164
Start date Nov 1, 1998
Primary completion Jun 1, 2009
Completion Jun 1, 2009
First posted Nov 25, 2004
Last update posted Sep 25, 2020
Countries Australia, Austria, Belgium, Brazil, Georgia, Hong Kong, India, Italy, Malaysia, Moldova, Netherlands, New Zealand and 8 more

At a glance

  • 100–999 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies